New research suggests hypofractionated radiation therapy (RT) offers similar results to standard RT in several key areas for stage II and III non-small cell lung cancer (NSCLC) patients who are unable to receive standard treatments of surgery or chemoradiation (CRT). Hypofractionated RT showed similar results in overall survival (OS) and progression-free survival (PFS) rates, limited severe side effects and shorter treatment times.

September 23, 2016 — IBA unveiled its new platform, 'Leading the PATh', which gathers the leading experts in the field of proton therapy all in one place. It is anticipated that 'Leading the PATh' will enable the worldwide medical community to shape the most efficient proton adaptive therapy (PATh), a proton therapy process which improves the accuracy of what is considered to be the most precise cancer treatment available today.

ZDi Solutions LLC announced that it will soon market its Z-System patient positioning devices to proton therapy and conventional radiation therapy facilities in the United States, with plans to collaborate worldwide. The system is comprised of the Z-Box, Z-Square and Z-Tilt. The team from ZDi will be attending the annual meeting of the American Society for Therapeutic Radiology and Oncology (ASTRO) in Boston Sept. 25-28 to demonstrate the technology.

September 23, 2016 — Three leading national cancer organizations issued a joint clinical practice guideline update for physicians treating women with breast cancer who have undergone a mastectomy. The update provides additional considerations for physicians to determine which patients might benefit from post-mastectomy radiotherapy (PMRT). 

Mevion Medical Systems announced that it will be installing its Mevion S250i proton therapy system at the Zuidoost Nederland Protonen Therapie Centrum, BV (ZON-PTC) in the Netherlands. The system delivers high-quality adaptive intensity modulated proton therapy (IMPT) with Mevion’s Hyperscan pencil beam scanning and Adaptive Aperture technology.

Vision RT announced it will be exhibiting at the American Society for Radiation Oncology (ASTRO) 2016 Annual Meeting Sept. 25-28 in Boston. New data will be released at this meeting from a trial at the National Cancer Institute (NCI)-accredited Lineberger Cancer Center at the University of North Carolina showing zero radiation-induced abnormalities in blood flow to the heart in all patients where Vision RT’s product was used in left breast radiotherapy.

At the 2016 Annual Meeting of the American Society for Radiation Oncology (ASTRO), Sept. 25-28 in Boston, Siemens Healthineers will debuts new hardware and software offerings for imaging for radiation therapy (RT). The new Somatom Confidence RT Pro dedicated computed tomography (CT) scanner is designed to reduce unnecessary workflow steps and features technology that is intended to advance quality care while enabling personalized scans. The scanner features the new version of the company’s optional software syngo.via RT Image Suite, which is designed to help radiation oncology professionals increase efficiency with integrated image assessment, contouring and patient marking in one solution.

Mevion Medical Systems will showcase its pencil beam scanning Hyperscan with Adaptive Aperture at the 2016 American Society for Radiation Oncology (ASTRO) Annual Meeting, Sept. 25-28 in Boston. The advanced proton micro-multileaf collimator (mMLC) technology is integrated into the Mevion S250i with Hyperscan, making pencil beam scanning sharper and faster and delivering robust intensity modulated proton therapy (IMPT).

Subscribe to
© Copyright Wainscot Media. All Rights Reserved.
Subscribe Now